Special cases for proton beam radio- therapy: re-irradiation, lymphoma, and breast cancer. Semin Oncol 2014; 41: 807-19.Special Cases for Proton Beam Radiotherapy: Re-irradiation, Lymphoma, and Breast Cancer[J] . John P. Plastaras,Abigail T. Berman,Gary M. Freedman.Seminars in Oncology ....
The potential of proton beam radiation therapy in breast cancer. Acta Oncol 2005; 44:884 A9.Bjork-Eriksson, T. and Glimelius, B. (2005), The potential of proton beam radiation therapy in breast cancer. Acta oncologica , 44, 8, 884-889....
PROTON therapyPATIENT participationINTENSITY modulated radiotherapyIn the accompanying editorial for our article,[1] Dr. Lee raised several valid points regarding our findings and, more broadly, the use of proton-beam therapy (PBT) in radiotherapy for prostate cancer (PC).[2] First, we would like...
The most common type of radiation therapy used to treatbreast canceris external beam radiation. A specialized type of this, called proton therapy, targets just the tumor so the surrounding healthy tissue is less likely to be harmed. Another name for this radiation treatment is intensity modulated...
New technical advances in proton beam delivery coupled with shortened overall treatment times and declining device costs have the potential to make this a more cost-effective therapy in the years ahead. Keywords: proton beam; radiation; prostate cancer; quality of life; cost; evidence...
1 More centres for proton beam therapy have subsequently been built in Europe since the 1990s. According to the particle therapy co-operative group (PTCOG; available online at www.ptcog.ch), the number of particle therapy facilities in operation in Europe is forecast to increase from the ...
Proton beam therapy is an emerging technology with promise of revolutionizing the treatment of cancer. While nearly half of all patients diagnosed with cancer in the US receive radiation therapy, the majority is delivered via electron accelerators, where photons are used to irradiate cancerous tissue...
Several studies have shown that BRCA1-mutated breast cancer cells are more sensitive to the cytotoxic effect of PARP inhibition than those that are BRCA1-intact5,6. Clinically, PARP inhibitors have improved outcomes compared with conventional therapy for both advanced and early-stage BRCA1/2-...
Advanced proton therapy—extreme precision, less radiation—at the Southeast's largest center: Emory Proton Therapy Center
The dose distributions that can be achieved with protons are usually superior to those of conventional photon external-beam radiation. There are special cases where proton therapy may offer a substantial potential benefit compared to photon treatments where toxicity concerns dominate. Re-irradiation may ...